# NUVECTIS PHARMA INC (NVCT)

> Institutional ownership reported to the SEC as of Q3 2026, from Form 13F filings. Source: https://holderbook.com/stocks/NVCT/

- Reporting holders: 2
- Reported value: $19.3K
- Held through calls: 0.0%
- Held through puts: 0.0%

A 13F reports long US equity positions only. Shorts, bonds, foreign listings and cash are not visible here, and positions are disclosed up to 45 days after the quarter ends.

## Largest holders

| Manager | Value | Shares | Share of their book | Quarters held |
|---|---|---|---|---|
| [GAMMA Investing LLC](https://holderbook.com/funds/2010235-gamma-investing-llc/) | $18.8K | 889 | 0.0% | 5 |
| [Farther Finance Advisors, LLC](https://holderbook.com/funds/1992825-farther-finance-advisors-llc/) | $570 | 27 | 0.0% | 2 |

## Quarter by quarter

| Quarter | Holders | Reported value |
|---|---|---|
| Q3 2026 | 2 | $19.3K |
| Q2 2026 | 86 | $215.4M |
| Q1 2026 | 64 | $35.1M |
| Q4 2025 | 51 | $33.9M |
| Q3 2025 | 55 | $23.3M |
| Q2 2025 | 48 | $25.5M |
| Q1 2025 | 36 | $22.2M |
| Q4 2024 | 31 | $7.1M |
| Q3 2024 | 31 | $6.6M |
| Q2 2024 | 40 | $7.7M |
| Q1 2024 | 40 | $13.5M |
| Q4 2023 | 36 | $12.9M |